1. Home
  2. PPBT vs CARV Comparison

PPBT vs CARV Comparison

Compare PPBT & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • CARV
  • Stock Information
  • Founded
  • PPBT 2010
  • CARV 1948
  • Country
  • PPBT Israel
  • CARV United States
  • Employees
  • PPBT N/A
  • CARV N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • PPBT Health Care
  • CARV Finance
  • Exchange
  • PPBT Nasdaq
  • CARV Nasdaq
  • Market Cap
  • PPBT 6.2M
  • CARV 7.3M
  • IPO Year
  • PPBT N/A
  • CARV 1994
  • Fundamental
  • Price
  • PPBT $2.53
  • CARV $1.84
  • Analyst Decision
  • PPBT Strong Buy
  • CARV
  • Analyst Count
  • PPBT 1
  • CARV 0
  • Target Price
  • PPBT $33.00
  • CARV N/A
  • AVG Volume (30 Days)
  • PPBT 18.2K
  • CARV 38.0K
  • Earning Date
  • PPBT 08-15-2025
  • CARV 08-13-2025
  • Dividend Yield
  • PPBT N/A
  • CARV N/A
  • EPS Growth
  • PPBT N/A
  • CARV N/A
  • EPS
  • PPBT N/A
  • CARV N/A
  • Revenue
  • PPBT N/A
  • CARV $21,046,000.00
  • Revenue This Year
  • PPBT N/A
  • CARV N/A
  • Revenue Next Year
  • PPBT N/A
  • CARV N/A
  • P/E Ratio
  • PPBT N/A
  • CARV N/A
  • Revenue Growth
  • PPBT N/A
  • CARV N/A
  • 52 Week Low
  • PPBT $2.00
  • CARV $1.30
  • 52 Week High
  • PPBT $13.95
  • CARV $2.20
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 56.04
  • CARV 64.24
  • Support Level
  • PPBT $2.35
  • CARV $1.63
  • Resistance Level
  • PPBT $2.58
  • CARV $1.95
  • Average True Range (ATR)
  • PPBT 0.12
  • CARV 0.16
  • MACD
  • PPBT 0.02
  • CARV 0.01
  • Stochastic Oscillator
  • PPBT 84.38
  • CARV 77.76

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: